Today: 9 June 2026
BAE Systems and Babcock shares jump as Iran war jolts markets and lifts defence spending bets
3 March 2026
2 mins read

BAE Systems and Babcock shares jump as Iran war jolts markets and lifts defence spending bets

LONDON, March 3, 2026, 09:42 GMT

Shares of BAE Systems surged 6.1% on Monday, with Babcock International up 1.7%, defying a broader London selloff as investors responded to the escalating conflict involving Iran and the prospect of increased defence budgets. The FTSE 100 dropped 1.2%, market data showed. Citi’s Charles Armitage noted that BAE, with roughly half its revenue tied to the U.S., stands to benefit most from any boost in American defence outlays.

Defence stocks surged after Iranian counterstrikes upended shipping in the Strait of Hormuz, sending oil sharply higher and triggering a sell-off in risk assets. The weekend airstrikes by Israel and the United States killed Iran’s Supreme Leader Ayatollah Ali Khamenei. “If the issues persist, the market will start to worry about new inflationary pressures,” said Dan Coatsworth, head of markets at AJ Bell, citing the threat of rising energy prices pushing back near-term rate cuts. Reuters

Morgan Stanley pointed out that the conflict could sharpen Europe’s focus on security and strategic autonomy, a backdrop the bank says supports its “overweight” stance on the sector—Wall Street code for predicting outperformance. The bank also flagged that a longer period of instability may push Gulf defence spending higher, and referenced a signal from the White House aiming to boost the U.S. defence budget by roughly 50%, up to $1.5 trillion by 2027. Around 45% of BAE’s revenue is tied to the U.S., with another 10% from the Gulf, Morgan Stanley estimated. Shares in BAE fell about 2% early Tuesday, following gains the previous day. Sharecast

Turbulence isn’t limited to stocks. President Donald Trump told Reuters the operation against Iran might stretch out over “the next four weeks.” Investors are also keeping an eye on the Strait of Hormuz, which moves roughly a fifth of the world’s oil. Reuters

Defence names climbed across Europe, shrugging off declines in the broader market. London-listed Qinetiq jumped 3.4%, joining gains for BAE and Babcock, while Leonardo in Italy advanced 4.2%. Shares in Germany’s Rheinmetall ticked up 2%, according to City AM. “The conflict in the Middle East has further outlined the need for defence budgets to rise,” said Aarin Chiekrie, equity analyst at Hargreaves Lansdown. JPMorgan analysts pointed to BAE’s footprint in U.S. missile-defence, spotlighting its supply of an infrared seeker for THAAD — or Terminal High Altitude Area Defense — which is designed to intercept ballistic missiles. City AM

Air-defence demands are now surfacing in government briefings. Italy’s Defence Minister Guido Crosetto told lawmakers that Gulf states are seeking air-defence and anti-drone equipment as the conflict intensifies—including the Franco-Italian SAMP/T battery, known as MAMBA. “The Gulf countries are expressing strong concern,” Crosetto said. But he noted supply remains tight, with Italy already committed to delivering SAMP/T systems to Ukraine. Reuters

Babcock, the UK-based defence, aerospace and security contractor, spans marine, nuclear, land, and aviation segments—with services from naval ship support and submarine work to fleet management and pilot instruction. The breadth of its business ties Babcock closely to lengthy government projects, where shifts in public budgets and procurement schedules can be just as crucial as today’s news flow.

BAE stands out as a heavyweight in the UK defence sector and is a key player in the FTSE 100. Its reach extends across aerospace, naval, land, and electronic systems, a recent sector briefing shows. With its sizable operations and a broad international client list, BAE often serves as the market’s preferred proxy for “higher spending” bets tied to rising geopolitical tensions. Kalkine Media

But it’s hardly a one-way bet. U.S. Defence Secretary Pete Hegseth pushed back on talk of an “endless war,” insisting the campaign’s real objective is to take out Tehran’s missiles, navy, and security infrastructure — signaling this may not spiral into a lengthy conflict. Still, any rapid move at the diplomatic table or a squeeze on public finances could put a brake on the defense spending surge that’s been boosting contractors. Reuters

Stock Market Today

  • $150M Cancer Proteomics Deal Spurs New NYSE Listing
    June 9, 2026, 9:34 AM EDT. A $150 million deal in functional proteomics, the study of protein functions and interactions critical for drug development, has led to the spin-out of a new company set to list on the New York Stock Exchange (NYSE). The company focuses on advanced cancer treatments including antibody-drug conjugates-targeted therapies combining antibodies with cell-killing agents to attack tumors precisely. Immunotherapies and targeted therapies featured in the pipeline aim to harness and guide the immune system to combat cancer effectively. Filing of the registration statement with regulators marks a key step toward public investment, enabling transparency. This development highlights the growing financial and clinical importance of proteomics in oncology and the biotech sector.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
National Grid share price drops nearly 3% as NG.L retreats after £70bn investment plan
Previous Story

National Grid share price drops nearly 3% as NG.L retreats after £70bn investment plan

Glencore share price slides 3% as war-driven oil shock hits London miners — what’s next for GLEN stock
Next Story

Glencore share price slides 3% as war-driven oil shock hits London miners — what’s next for GLEN stock

Go toTop